Anthem Biosciences Limited (ANTHEM)

Name: Anthem Biosciences Limited (ANTHEM) — historial de estados financieros
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.

Healthcare · Wall Street (EE. UU.) · Última actualización: 2026-09-20

Anthem Biosciences Limited operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally. It operates in two segments: Contract Manufacturing, Development & Discovery Services; and Speciality Ingredients.

Cifras clave

Capitalización bursátil: ₹522 billion
Ingresos (ejercicio cerrado en 2026-03-31): ₹21.2B
Beneficio neto: ₹5.9B
Margen bruto: 61.8%
Margen neto: 27.9%

Ver gráficos interactivos y estados completos →

Cuenta de resultados anual

Cuenta de resultados	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Ingresos totales	₹21.2B	₹18.4B	₹14.2B	₹10.6B	—
Beneficio bruto	₹13.1B	₹11.0B	₹8.2B	₹7.2B	—
Ingresos operativos (EBIT)	₹7.1B	₹5.9B	₹4.2B	₹3.7B	—
Ingresos netos	₹5.9B	₹4.5B	₹3.7B	₹3.9B	—

Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.

Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de ANTHEM. /companies/us/ANTHEM

Empresas similares

La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.

English version →Todas las acciones

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.